Abstract:OBJECTIVE: Neurodevelopmental disorders presumably involve events that occur during brain development. The authors hypothesized that neuropsychiatric disorders considered to be developmental in etiology are associated with susceptibility genes that are relatively upregulated during fetal life (i.e., differentially expressed).METHOD: The authors investigated the presence of prenatal expression enrichment of susceptibility genes systematically, as composite gene sets associated with six neuropsychiatric disorders in the microarray-based "BrainCloud" dorsolateral prefrontal cortex transcriptome.RESULTS: Using a fetal/postnatal log2-fold change threshold of 0.5, genes associated with syndromic neurodevelopmental disorders (N=31 genes, p=3.37×10-3), intellectual disability (N=88 genes, p=5.53×10-3), and autism spectrum disorder (N=242 genes, p=3.45×10-4) were relatively enriched in prenatal transcript abundance, compared with the overall transcriptome. Genes associated with schizophrenia by genome-wide association studies were not preferentially fetally expressed (N=106 genes, p=0.46), nor were genes associated with schizophrenia by exome sequencing (N=212 genes, p=0.21), but specific genes within copy-number variant regions associated with schizophrenia were relatively enriched in prenatal transcript abundance, and genes associated with schizophrenia by meta-analysis were functionally enriched for some neurodevelopmental processes. In contrast, genes associated with neurodegenerative disorders were significantly underexpressed during fetal life (N=46 genes, p=1.67×10-3).CONCLUSIONS: The authors found evidence for relative prenatal enrichment of putative susceptibility genes for syndromic neurodevelopmental disorders, intellectual disability, and autism spectrum disorder. Future transcriptome-level association studies should evaluate regions other than the dorsolateral prefrontal cortex, at other time points, and incorporate further RNA sequencing analyses.

Expression quantitative trait loci in the developing human brain and their enrichment in neuropsychiatric disorders

Cross-ancestry, cell-type-informed atlas of gene, isoform, and splicing regulation in the developing human brain

Cis-effects on gene expression in the human prenatal brain associated with genetic risk for neuropsychiatric disorders

Developmental and genetic regulation of the human cortex transcriptome illuminate schizophrenia pathogenesis

Prenatal Expression Patterns of Genes Associated With Neuropsychiatric Disorders

Single-Nuclei RNA Sequencing of 5 Regions of the Human Prenatal Brain Implicates Developing Neuron Populations in Genetic Risk for Schizophrenia

Chromatin accessibility during human first-trimester neurodevelopment

Genetics of cell-type-specific post-transcriptional gene regulation during human neurogenesis

Multi-ancestry eQTL meta-analysis of human brain identifies candidate causal variants for brain-related traits

Expression quantitative trait loci (eQTLs) in human placentas suggest developmental origins of complex diseases

Genetic regulation of human brain proteome reveals proteins implicated in psychiatric disorders

Genetic Control of the Human Brain Proteome

Chromosome conformation elucidates regulatory relationships in developing human brain

A transcriptomic atlas of the human brain reveals genetically determined aspects of neuropsychiatric health

Genetic regulation of cell type–specific chromatin accessibility shapes brain disease etiology

Functional genomics of human brain development and implications for autism spectrum disorders

BrainSeq: Neurogenomics to Drive Novel Target Discovery for Neuropsychiatric Disorders

Brain expression quantitative trait locus and network analyses reveal downstream effects and putative drivers for brain-related diseases

Genetic regulation of lncRNA expression in the whole human brain

Single-cell analysis of prenatal and postnatal human cortical development

Transcriptome and epigenome landscape of human cortical development modeled in organoids.